JPRN-jRCTs041180093招募中2 期
Anticoagulant threpy for patients with obstetric antiphospholipid syndrome.
Sugiura Mayumi0 个研究点目标入组 200 人开始时间: 2019年3月13日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- Female
入选标准
- •Two or more early miscarriage
- •One or more fetal death
- •Preterm birth <34 weeks' gestation caused by preeclampsia or placental dysfunction
- •Antiphospholipid antibodies continue positive for 12 weeks.
排除标准
- •abnormal chromosome in either partner
- •uterine anomaly
- •bleeding disease, renal dysfunction, liver dysfunction
研究者
相似试验
进行中（未招募）
1 期
Anticoagulants for living fetuses for women with recurrent miscarriage and inherited blood clotting disorders; ALIFE2 studyEUCTR2012-001447-43-ATAcademic Medical Center Amsterdam399
招募中
3 期
Anticoagulants for Living Fetuses in women with recurrent miscarriage and inherited thrombophilia; ALIFE2 studyhabitual abortionrecurrent miscarriage1006447710000211NL-OMON43583Academisch Medisch Centrum200
招募中
不适用
Anticoagulants for living fetuses for women with recurrent miscarriage and inherited blood clotting disorders.recurrent miscarriageinherited thrombophiliaNL-OMON27965Academic Medical Center Amsterdam399
进行中（未招募）
1 期
Anticoagulants (blooding thinning medications) for pregnant women who have suffered 2 or more miscarriages and inherited thrombophilia (increased clotting tendency)Inherited thrombophilia in recurrent miscarriageEUCTR2015-002357-35-GBResearch, Development & Innovation Department, UHCW NHS Trust400
已完成
2 期
the effect of plavix in post coronary artery bypass graft/coronary endarterectomy patientsCoronary artery disease.Atherosclerotic heart disease Coronary (artery): atheroma atherosclerosis disease sclerosisIRCT2016102730410N2Babol University of Medical Sciences, Deputy of Research & Technology55